Citi Corporate and Investment Banking
Kevin J. Gallagher, Director

Kevin Gallagher is a Director in the Global Healthcare group of Citi’s Corporate and Investment Banking division. Kevin specializes in the Medical Technology sector with responsibility for emerging growth companies. Prior to joining Citi in July 2007, Kevin spent over eight years advising healthcare companies as part of organizations including Thomas Wiesel Partners, HealthpointCapital and UBS. He has completed over 50 corporate finance and M&A transactions to date. Kevin earned his bachelor’s degree from Dartmouth College.

Citi, a leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management. Citi has one of the leading healthcare investment banking franchises, with seventy seven professionals in seven countries across three continents, and top ranked positions in all relevant financial products. Citi’s Global Healthcare group has announced 161 M&A, debt and equity transactions since the beginning of 2011, including over $79 billion of healthcare M&A deal volume.